$OKLO

Oklo Inc.

CIK:0001849056|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 1,210	$ 0	$ 1,210	$ 0
Operating expenses
Cost of sales	721	0	721	0
Research and development	39,474	11,468	66,523	19,314
General and administrative	34,205	16,547	58,132	26,575
Total operating expenses	74,400	28,015	125,376	45,889
Loss from operations	(73,190)	(28,015)	(124,166)	(45,889)
Other income (expense)
Interest and dividend income, net	23,209	3,761	44,548	7,414
Other non-operating expenses	(1,708)	0	(1,981)	0
Total other income (expense)	21,501	3,761	42,567	7,414
Loss before income taxes	(51,689)	(24,254)	(81,599)	(38,475)
Income tax benefit (expense)	3,153	(431)	(2)	3,980
Net loss	$ (48,536)	$ (24,685)	$ (81,601)	$ (34,495)
Net loss per share:
Basic - Class A common stock (in dollars per share)	$ (0.28)	$ (0.18)	$ (0.47)	$ (0.25)
Diluted - Class A common stock (in dollars per share)	$ (0.28)	$ (0.18)	$ (0.47)	$ (0.25)
Weighted-average common shares outstanding - basic - Class A common stock (in shares)	176,224,404	140,085,498	173,295,347	139,103,193
Weighted-average common shares outstanding - diluted - Class A common stock (in shares)	176,224,404	140,085,498	173,295,347	139,103,193

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net loss	$ (81,601,000)	$ (34,495,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	500,000	249,000
Interest income and accretion of discount on marketable debt securities, net	891,000	(342,000)
Stock-based compensation	29,944,000	13,676,000
Deferred income tax expense (credit)	2,000	(4,734,000)
Other	9,000	0
Change in operating assets and liabilities, net of effect of acquisitions:
Prepaid expenses and other current assets	(10,798,000)	(4,013,000)
Accounts receivable	517,000	0
Other assets	(17,513,000)	(21,000)
Accounts payable	3,263,000	(2,456,000)
Accrued expenses and other	9,343,000	1,390,000
Operating lease right-of-use assets and liabilities	33,000	32,000
Other liabilities	(49,000)	0
Net cash used in operating activities	(65,459,000)	(30,714,000)
Cash flows from investing activities:
Purchases of property, plant and equipment	(126,901,000)	(1,209,000)
Purchases of marketable debt securities	(1,176,421,000)	(346,604,000)
Proceeds from redemptions of marketable debt securities	432,827,000	68,017,000
Payment for acquisition of businesses, net of cash acquired	25,736,000	900,000
Other investments	(16,500,000)	0
Net cash used in investing activities	(912,731,000)	(280,696,000)
Cash flows from financing activities:
Payment of taxes from common stock withheld	(75,000)	(1,595,000)
Proceeds from exercise of stock options	1,597,000	1,348,000
Payment of offering costs and deferred issuance costs	0	(304,000)
Payment of finance lease liability	(750,000)	0
Payment of debt	(1,367,000)	0
Proceeds from sale of common stock, net of offering costs	1,851,944,000	441,600,000
Net cash provided by financing activities	1,851,349,000	441,049,000
Net increase in cash, cash equivalents and restricted cash	873,159,000	129,639,000
Cash, cash equivalents and restricted cash - beginning of period	788,445,000	97,132,000
Cash, cash equivalents and restricted cash - end of period	1,661,604,000	226,771,000
Cash, cash equivalents, and restricted cash
Cash and cash equivalents	1,644,704,000	226,771,000
Restricted cash	8,400,000	0
Restricted cash, noncurrent portion	8,500,000	0
Total cash, cash equivalents, and restricted cash	1,661,604,000	226,771,000
Supplemental disclosures of cash flow information:
Cash paid for interest	54,000	0
Cash paid for income taxes	0	660,000
Supplemental noncash investing and financing activities:
Issuance of common stock in connection with acquisition of business	0	27,408,000
Assumed liabilities in connection with acquisition of businesses	3,585,000	287,000
Purchases of property, plant and equipment in accounts payable and accrued expense and other	9,008,000	1,509,000
Offering costs included in accounts payable	0	1,132,000
Offering costs included in accrued expense and other	0	62,000
Holdback liabilities in connection with the acquisition of businesses	4,066,000	0
Contingent consideration in connection with the acquisition of business	3,110,000	0
Settlement of accounts payable in connection with acquisition of businesses	$ 564,000	$ 0

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 1,644,704	$ 788,445
Restricted cash	8,400	0
Marketable debt securities	820,454	439,526
Accounts receivable, net	1,979	0
Prepaid expenses and other current assets	45,372	25,798
Total current assets	2,520,909	1,253,769
Restricted cash, noncurrent portion	8,500	0
Marketable debt securities, net of current portion	541,131	184,568
Property, plant and equipment, net	176,195	42,312
Operating lease right-of-use assets	3,160	1,384
Intangible assets, net	44,203	27,500
Goodwill	16,535	6,621
Other assets	47,249	12,303
Total assets	3,357,882	1,528,457
Current liabilities:
Accounts payable	10,470	4,145
Accrued expenses and other	38,023	20,497
Operating lease liabilities	1,025	904
Other current liabilities	2,499	0
Total current liabilities	52,017	25,546
Operating lease liabilities, net of current portion	2,234	546
Long-term debt, net of current portion	700	0
Right of first refusal liability	25,000	25,000
Deferred tax liabilities	1,157	1,155
Other liabilities	3,217	0
Total liabilities	84,325	52,247
Commitments and contingencies
Stockholders' equity:
Class A common stock, $0.0001 par value – 500,000,000 shares authorized; 185,090,155 and 160,514,103 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	18	16
Additional paid-in capital	3,599,945	1,715,787
Accumulated deficit	(322,373)	(240,772)
Accumulated other comprehensive (loss) income	(4,033)	1,179
Total stockholders’ equity	3,273,557	1,476,210
Total liabilities and stockholders’ equity	$ 3,357,882	$ 1,528,457